Clairo

Assistant Clinical Project Manager, Oncology

India

Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Oncology, Clinical Research, PharmaceuticalsIndustries

Requirements

An Associate's Degree is required, with a Bachelor's Degree preferred. A minimum of 1 year of experience in pharmaceutical drug development, clinical trials, or clinical research is preferred. Strong proficiency in Microsoft Office Suite is essential. Prior healthcare, medical, or clinical research experience is a plus. Excellent organizational, interpersonal, time management, and prioritization skills are necessary, along with strong verbal and written communication abilities in English. Candidates must be detail-oriented, able to work independently and collaboratively, adapt to changing priorities, and maintain a professional attitude.

Responsibilities

The Assistant Clinical Project Manager will assist Clinical Project Managers with project administration, including developing documents, reviewing presentations, and participating in meetings. They will act as a liaison for timely completion of study deliverables, report study needs, and support project start-up, execution, and close-out. Responsibilities include assisting with finance-related activities, monitoring data flow, responding to inquiries, communicating project status to clients, verifying imaging requirements, and serving as acting Project Manager when needed. They will also create and distribute project reports, ensure adherence to project timelines by following up on outstanding items, assist in tracking client issues, and serve as an additional point of contact. Maintaining quality service by adhering to SOPs, executing technical and clinical functions per protocol, and participating in process improvement initiatives are key. Secondary responsibilities include contributing to team efforts, attending training, and performing other assigned duties.

Skills

Project Administration
Document Review
Presentation Editing
Project Meetings
Protocol Understanding
Cross-functional Liaison
Deliverable Management
Issue Reporting
Project Start-up
Project Execution
Project Close-out
Finance Support
Invoice Reconciliation
Project Forecasting
Data Flow Monitoring
Client Communication
Protocol Imaging Requirements
Standard Operating Procedures (SOPs)

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI